Latest Prostate cancer Stories
Active Surveillance Provides Low-Risk Patients Less Harmful Treatment Option NORTHFIELD, Ill., Aug.
9th Annual Race Supports Lung Cancer Research SOUTHAMPTON, N.Y., Aug.
POINT ROBERTS, Wash. and NEW YORK, Aug.
Demands Manufacturers Prove Claims of Safety and Benefits For Prostate Cancer Treatments CORAL SPRINGS, Fla., Aug.
According to relationship specialist Dr.
OXFORD, England, July 29, 2014 /PRNewswire/ -- Glide Pharmaceutical Technologies Ltd (Glide Pharma) today announced that it has taken an exclusive worldwide licence to
ROCKLAND, Massachusetts, July 29, 2014 /PRNewswire/ -- - First patient begins treatment in an international Phase II study investigating the efficacy
Individuals diagnosed with a covered Cancer on or prior to October 12, 2012 are included in the October 12, 2014 deadline. Port Washington, NY (PRWEB) July 28,
Discovery Accepted into NCI Drug Development Program for Clinical Trials Philadelphia, PA (PRWEB) July 28, 2014 An estimated 68,000 women and men in
Phase I studies start in 2015 NEW HAVEN, Conn., July 25, 2014 /PRNewswire/ -- Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd.
- A trick or prank.
More Images (2 images) »